Cargando…
Attitudes of patients with cutaneous melanoma toward prognostic testing using the 31‐gene expression profile test
OBJECTIVE: Although most patients diagnosed with early‐stage cutaneous melanoma (CM) have excellent outcomes, because of the large number diagnosed each year, many will experience recurrence or death. Prognostic testing for CM using the 31‐gene expression profile (31‐GEP) test can benefit patients b...
Autores principales: | Ahmed, Kelli, Siegel, Jennifer J., Morgan‐Linnell, Sonia K., LiPira, Kyleigh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883557/ https://www.ncbi.nlm.nih.gov/pubmed/35915969 http://dx.doi.org/10.1002/cam4.5047 |
Ejemplares similares
-
Uveal melanoma patient attitudes towards prognostic testing using gene expression profiling
por: Williams, Basil K, et al.
Publicado: (2022) -
Prospective validation of the prognostic 31‐gene expression profiling test in primary cutaneous melanoma
por: Keller, Jennifer, et al.
Publicado: (2019) -
Performance of a 31‐gene expression profile test in cutaneous melanomas of the head and neck
por: Gastman, Brian R., et al.
Publicado: (2019) -
Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test
por: Hsueh, Eddy C., et al.
Publicado: (2017) -
Erratum to: Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test
por: Hsueh, Eddy C., et al.
Publicado: (2017)